HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Macronutrient Intake-Associated FGF21 Genotype Modifies Effects of Weight-Loss Diets on 2-Year Changes of Central Adiposity and Body Composition: The POUNDS Lost Trial.

AbstractOBJECTIVE:
Fibroblast growth factor 21 (FGF21) is involved in the regulation of energy balance and adipose metabolism. Our previous genome-wide association study identified genetic variants in the FGF21 region associated with macronutrient intake preference. We investigated whether the FGF21 genotype modified effects of weight-loss diets varying in macronutrient intake on changes in adiposity in a 2-year randomized diet intervention trial.
RESEARCH DESIGN AND METHODS:
We genotyped FGF21 rs838147 in 715 overweight or obese individuals who were assigned to one of four diets varying in macronutrient contents. A DEXA scan was performed to evaluate body composition.
RESULTS:
We observed a significant interaction between the FGF21 genotype and carbohydrate/fat intake on 2-year changes in waist circumference (WC), percentage of total fat mass, and percentage of trunk fat (P = 0.049, P = 0.001, and P = 0.003 for interaction, respectively). In response to the low-carbohydrate/high-fat diet, carrying the carbohydrate intake-decreasing C allele of rs838147 was marginally associated with less reduction in WC (P = 0.08) and significantly associated with less reduction of total fat mass (P = 0.01) and trunk fat (P = 0.02). Opposite genetic associations with these outcomes were observed among the high-carbohydrate/low-fat diet group; carrying the C allele was associated with a greater reduction of WC, total body fat mass, and trunk fat.
CONCLUSIONS:
Our data suggest that FGF21 genotypes may interact with dietary carbohydrate/fat intake on changes in central adiposity and body fat composition. A low-calorie, high-carbohydrate/low-fat diet was beneficial for overweight or obese individuals carrying the carbohydrate intake-decreasing allele of the FGF21 variant to improve body composition and abdominal obesity.
AuthorsYoriko Heianza, Wenjie Ma, Tao Huang, Tiange Wang, Yan Zheng, Steven R Smith, George A Bray, Frank M Sacks, Lu Qi
JournalDiabetes care (Diabetes Care) Vol. 39 Issue 11 Pg. 1909-1914 (Nov 2016) ISSN: 1935-5548 [Electronic] United States
PMID27581055 (Publication Type: Journal Article)
Copyright© 2016 by the American Diabetes Association.
Chemical References
  • Dietary Carbohydrates
  • Dietary Fats
  • fibroblast growth factor 21
  • Fibroblast Growth Factors
Topics
  • Adiposity (genetics)
  • Adult
  • Alleles
  • Body Composition (genetics)
  • Caloric Restriction
  • Diet, Fat-Restricted
  • Diet, High-Fat
  • Diet, Reducing
  • Dietary Carbohydrates
  • Dietary Fats
  • Energy Intake
  • Female
  • Fibroblast Growth Factors (genetics)
  • Genome-Wide Association Study
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Obesity (diet therapy)
  • Obesity, Abdominal (genetics)
  • Overweight (diet therapy)
  • Polymorphism, Single Nucleotide
  • Randomized Controlled Trials as Topic
  • Treatment Outcome
  • Waist Circumference
  • Weight Loss (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: